Axial Therapeutics Announces First Patient Dosed in Phase 1b/2a Clinical Trial of AB-2004 for Treatment of Gastrointestinal Dysfunction and Associated Behavioral Symptoms of Autism Spectrum Disorder July 16, 2019
Pulmocide Announces Nature Research Publication Showing PC945 in Combination with Standard Antifungal Treatment Causes a Synergistic Effect Against Aspergillus Fumigatus July 8, 2019
Calithera Biosciences Initiates Phase 1/2 Trial of Telaglenastat in Combination with Pfizer’s CDK4/6 Inhibitor Palbociclib July 2, 2019
